Accommodation | Angelo Hotel
Radlická 1g
CZ-150 00
Prague 5
Czech Republic
|
Meeting Venue | Andel’s Hotel
Stroupeznickeho 21
CZ-150 Prague
Czech Republic
Note: Angelo Hotel is adjacent to Andel’s Hotel and both are located in the same hotel complex.
|
 Agenda |
Untitled Document
| Friday, 9 October 2009 |
| 20.00-22.30 |
Welcome reception and buffet dinner |
| |
|
| Saturday, 10 October 2009 |
| 08.45 |
Welcome, introduction and demographics
Paolo Pronzato, MD
Bojana Pajk, MD |
| 09.00 |
Adjuvant endocrine therapy in 2009: Incorporating data from SABCS and St Gallen into daily clinical practice
Daniel Rea, MD, PhD |
| 09.30 |
Case #1—The use of gene expression profiles in node-negative, endocrine-responsive early breast cancer
Paolo Pronzato, MD |
| 10.00 |
Questions and Answers |
| 10.05 |
Case #2—Adjuvant endocrine therapy for a postmenopausal patient at intermediate risk of recurrence
Jean-Phillippe Spano, MD, PhD |
| 10.35 |
Questions and Answers |
| 10.40 |
Break |
| 11.00 |
Case #3—Perimenopausal breast cancer: What is the optimal therapy?
Daniel Rea, MD, PhD |
| 11.30 |
Questions and Answers |
| 11.35 |
Case #4—Management of endocrine-responsive metastatic breast cancer
Jean-Phillippe Spano, MD, PhD |
| 12.05 |
Questions and Answers |
| 12.10 |
Case #5—Targeted therapy for HER2-overexpressing metastatic breast cancer
Javier Cortés, MD |
| 12.40 |
Questions and Answers |
| 12.45 |
Lunch |
| 13.45 |
Case #6—Management of metastatic breast cancer with disease progression following treatment with an anthracycline and taxane
Joachim Bischoff, MD |
| 14.15 |
Questions and Answers |
| 14.20 |
Case #7—Exploring the role of non-anthracycline regimens in early breast cancer
Paolo Pronzato, MD
|
| 14.50 |
Questions and Answers |
| 14.55 |
Case #8—Current management of recurrent triple-negative breast cancer: What’s the best approach?
Javier Cortés, MD |
| 15.25 |
Questions and Answers |
| 15.30 |
Concluding Remarks
Paolo Pronzato, MD |
|
|
